through controlled clinical development. It operates a pipeline that integrates biologic drug research with data from human and preclinical studies to support regulatory progression and therapeutic evaluation. Angitia Biopharmaceuticals engages with medical and scientific communities to share clinical data and refine development strategies. The organization focuses on drug discovery and development processes that respond to defined clinical needs in musculoskeletal health.